Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
Conditions:   Adnexal Mass;   Germline BRCA1 Gene Mutation;   Germline BRCA2 Gene Mutation;   Hereditary Breast and Ovarian Cancer
Intervention:   Other: OVA360
Sponsor:   Aspira Women’s Health
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 17, 2020 / by / in
Comments